LAYN and neoplasm: Elevated expression of layilin predicts a better response to anti-VEGFR2 and anti-PD-1 combination therapy in lung adenocarcinoma, which is mechanistically linked to the downregulation of layilin in tumor-infiltrating CD8+ T cells (13).